<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24474106</article-id>
      <article-id pub-id-type="pmc">3900348</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132378</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bullous pemphigoid in a 3-month-old infant: case report and literature
review of this dermatosis in childhood<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Penfigoide bolhoso em lactente de 3 meses: relato de caso e revis&#xE3;o de
literatura da dermatose na inf&#xE2;ncia</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Reis-Filho</surname>
            <given-names>Eugenio Galdino de Mendon&#xE7;a</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Tainah de Almeida</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aguirre</surname>
            <given-names>Luiza Helena de Lima</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reis</surname>
            <given-names>Carmelia Matos Santiago</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD, Board certified dermatologist - Professor of dermatology at
Brasilia Catholic University (UCB). Dermatologist at the Distrito Federal Health State
Secretariat (SES-DF) - Bras&#xED;lia (DF), Brazil.</aff>
      <aff id="aff02"><label>2</label> MD - Resident in Dermatology at Asa Norte Regional Hospital (HRAN) -
Bras&#xED;lia (DF), Brazil.</aff>
      <aff id="aff03"><label>3</label> MD, Board certified dermatologist. Preceptor of the Dermatology
Residency Program at Asa Norte Regional Hospital (HRAN) - Bras&#xED;lia (DF), Brazil.</aff>
      <aff id="aff04"><label>4</label> MD, PhD in Dermatology at Rio de Janeiro Federal University (UFRJ) -
Chief of the Dermatology Service at Asa Norte Regional Hospital (HRAN) - Bras&#xED;lia (DF),
Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>MAILING ADDRESS:</bold> Eugenio Galdino de Mendon&#xE7;a Reis-Filho, Setor Medico
Hospitalar Norte, Quadra 101 - Asa Norte, 70710-100 - Bras&#xED;lia - DF, Brazil. E-mail:
<email>eugeniodermato@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6</issue>
      <fpage>961</fpage>
      <lpage>965</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Bullous pemphigoid is an autoimmune subepidermal blistering dermatosis that is
uncommon in childhood. We report a case of a female infant, 3 months old, which
presented clinical and laboratory data for the confirmatory diagnosis of bullous
pemphigoid. The authors used immunohistochemical staining for collagen type IV that
allowed the differentiation of bullous pemphigoid from other subepidermal bullous
diseases. Opportunely we review the clinical, immunological, therapeutic and
prognostic features of this pathology in children.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>O penfigoide bolhoso &#xE9; uma dermatose bolhosa autoimune subepid&#xE9;rmica, incomum na
inf&#xE2;ncia. Relatamos um caso de lactente feminina, com 3 meses de idade, que
apresentou dados cl&#xED;nicos e laboratoriais confirmat&#xF3;rios para o diagn&#xF3;stico de
penfigoide bolhoso. Os autores utilizaram a colora&#xE7;&#xE3;o de imuno-histoqu&#xED;mica para o
col&#xE1;geno tipo IV que permitiu a diferencia&#xE7;&#xE3;o do penfigoide bolhoso de outras buloses
subepid&#xE9;rmicas. Oportunamente, revisamos as caracter&#xED;sticas cl&#xED;nicas, imunol&#xF3;gicas,
terap&#xEA;uticas e progn&#xF3;sticas da patologia na crian&#xE7;a.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Child</kwd>
        <kwd>Collagen type IV</kwd>
        <kwd>Pemphigoid, bullous</kwd>
        <kwd>Skin diseases, vesiculobullous</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Bullous pemphigoid (BP) is an acquired disease that belongs to the group of autoimmune
subepidermic bullous disorders. It features circulating autoantibodies against
distinctive skin's basal membrane antigens and adjacent mucous membrane's
antigens.<sup><xref ref-type="bibr" rid="r01">1</xref>-<xref ref-type="bibr" rid="r06">6</xref></sup> Its incidence increases with age, contrary to almost all
of the autoimmune disorders.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> It is
uncommon for the disease to begin during childhood and even more so during
infancy.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref>-<xref ref-type="bibr" rid="r12">12</xref></sup></p>
      <p>PB has a polymorphic clinical presentation. Vesicles and blisters arise on erythematous
or apparently healthy skin combined with pruriginous, erythematous infiltrated papules
and plaques with irregular borders, annular and polycyclic configurations (sometimes
similar to erythema multiforme), which may precede or coexist with blisters.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref></sup> Blisters are tight,
with variable size, usually symmetrical and ungrouped, with serous and / or hemorrhagic
contents.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> They are located
primarily on flexural areas of the limbs, trunk and abdomen. Face, head and neck are
often affected.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref></sup> Itching is
characteristic. Nikolsky sign is negative.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Diagnosis is based on clinical, histopathological and
immunofluorescence exams, particularly DIF (direct immunofluorescence) and salt-split
skin technique, traditionally used to differentiate BP from other immune subepidermal
bullous diseases.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r14">14</xref></sup></p>
      <p>The clinical, histopathological and immunopathologic characteristics of this disease
during childhood overlap with those in the adult form.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup> However, some peculiarities are present in childhood BP,
such as preferential involvement of palmoplantar regions, oral and genital mucosae and
face.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r15">15</xref></sup> Bullous
pemphigoid during childhood has a benign, self-limited evolution, with good response to
treatment with corticosteroids, lower recurrence rates and better prognosis when
compared to the adult form.<sup><xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r13">13</xref></sup></p>
    </sec>
    <sec>
      <title>CLINICAL CASE</title>
      <p>White infant female, three months and fifteen days old, developed multiple tight bullae
five days ago, initially on palms and soles, with progressive involvement of trunk,
limbs and head, accompanied by papules and plaques associated or not to blisters.
Parents were not consanguineous, denied fever or use of medications, as well as other
comorbidities. Personal and family history of atopy, other cutaneous diseases or
autoimmune disorders was negative. The patient was born vaginally, at term, without
complications. Exclusively breastfed. The patient received the recommended vaccines,
with the last dose about 45 days previously.</p>
      <p>Dermatological examination revealed the presence of multiple vesicles and widespread
tight blisters with serous content and in different sizes, affecting areas of normal as
well as erythematous skin. She presented serohemorrhagic crusts, papules and annular
urticarial erythematous plaques, some topped by vesicles and blisters. Lesions were
located predominantly in the hands, feet, scalp, limbs, trunk and back. There were no
mucosal lesions. Nikolsky sign was negative (<xref ref-type="fig" rid="f01">Figures
1</xref> to <xref ref-type="fig" rid="f06">6</xref>). Complete blood count showed
mild anemia (hemoglobin: 10.8 g / dL), eosinophilia (2,300 eosinophils/mm<sup>3</sup> or
26% of total leukocytes) and thrombocytosis (585,000 platelets). Histopathology showed
spongiotic dermatitis with subepidermal bullae rich in neutrophils and eosinophils. DIF
detected the presence of linear IgG and C3 deposits along the subepidermal basal
membrane zone. Immunohistochemical staining for type IV collagen was positive at the
base of the blister, demonstrating that cleaving occurred above the lamina densa.
Saltsplit skin technique and IIFs (indirect immunofluorescence) could not be performed.
(<xref ref-type="fig" rid="f07">Figures 7</xref> to <xref ref-type="fig" rid="f10">10</xref>)</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Presence of multiple tight, widespread vesicles in areas of normal and
erythematous skin</p>
        </caption>
        <graphic xlink:href="abd-88-06-0961-g01"/>
      </fig>
      <fig id="f06" orientation="portrait" position="float">
        <label>FIGURE 6</label>
        <caption>
          <p>Detail of the trunk with early lesions, and head with serohemorrhagic crusts</p>
        </caption>
        <graphic xlink:href="abd-88-06-0961-g06"/>
      </fig>
      <fig id="f07" orientation="portrait" position="float">
        <label>FIGURE 7</label>
        <caption>
          <p>HE 10x: Spongiotic dermatitis with presence of subepidermal blister rich in
neutrophils and eosinophils</p>
        </caption>
        <graphic xlink:href="abd-88-06-0961-g07"/>
      </fig>
      <fig id="f10" orientation="portrait" position="float">
        <label>FIGURE 10</label>
        <caption>
          <p>Cryostat section with immunohistochemical reaction for type IV collagen showing
positivity on the base of the blister</p>
        </caption>
        <graphic xlink:href="abd-88-06-0961-g10"/>
      </fig>
      <p>The set of clinical and laboratory data confirmed the diagnosis of infantile bullous
pemphigoid. Treatment was started with prednisolone 1mg/kg. After five days, due to
partial response, the dose of prednisolone was increased to 2mg/kg/day. Reassessment
after fifteen days showed good control of the lesions, with only sparse escape blisters.
Vaccinations were suspended on account of the immunosuppressive doses of
corticosteroids. In order to permit corticosteroid weaning, dapsone was initiated at 0.5
mg / kg. Previous control exams had shown normal G6PD levels and no subsequent worsening
of anemia occurred with medication. Corticosteroid therapy was reduced by 0.5 mg / kg
every two weeks until its full suspension, while dapsone was maintained at 0.5 mg / kg /
day. Patient remained without skin lesions for three months, and resumed the use of
vaccines without live antigens according to the national vaccination calendar. At nine
months old, she received acellular conjugated vaccines (DTPA), anti hepatitis B, polio
and meningococcal diseases, with subsequent display of new bullous lesions. Dapsone was
increased to a dose of 1mg/kg and prednisolone 1mg/kg was initiated for a week. With
regression of the clinical symptoms dapsone was maintained for six months in which
period no new lesions appeared, even with the use of vaccines, so, the medication was
discontinued. The patient is followed-up in the outpatient dermatology service, and she
has been lesion-free for six months without any signs of recurrence to date.</p>
    </sec>
    <sec>
      <title>DISCUSSION AND CONCLUSION</title>
      <p>The precise incidence of bullous pemphigoid in children and other bullous dermatoses in
childhood are unknown.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r13">13</xref></sup>
The first case of juvenile BP confirmed by immunofluorescence was published in
1970.<sup><xref ref-type="bibr" rid="r07">7</xref></sup> Since then, there has
been a notable increase in published cases; currently there are just under 100 cases
reported in childhood, a dozen in infants.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup></p>
      <p>In BP, there is concrete evidence that circulating antibodies have a key role in disease
pathogenesis, reacting against epidermic basal membrane antigens, proteins BP180 antigen
(antigen-2 BP) and BP230 antigen (antigen-1 BP) causing tissue injury.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r16">16</xref></sup> These proteins are components of
adhesion junctional complexes, or hemidesmosomes, expressed in stratified
epithelia.<sup><xref ref-type="bibr" rid="r01">1</xref></sup></p>
      <p>Bullous pemphigoid can simulate various dermatoses and be clinically indistinguishable
from other bullous diseases of childhood, such as dermatitis herpetiformis, acquired
epidermolysis bullosa, bullous systemic lupus erythematosus or linear IgA bullous
dermatosis. Besides medical history, physical examination and histopathological
analysis, we use tests such as immunofluorescence, indirect immunofluorescence (with
salt-split skin technique), immunoblotting and ELISA for diagnosis.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r17">17</xref>,<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r20">20</xref></sup></p>
      <p>In this case, the question is whether the prior administration of vaccines did act as a
trigger for the formation of autoantigens against the basal membrane.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r21">21</xref></sup>
It is suggested that, in these cases, induced BP occurs through modulation of
immunity.<sup><xref ref-type="bibr" rid="r07">7</xref></sup> The vaccine could
unmask a subclinical BP inducing a nonspecific immune reactivation in genetically
predisposed individuals.<sup><xref ref-type="bibr" rid="r10">10</xref></sup> However,
the true role of vaccine antigens in the emergence of the BP is still
questioned.<sup><xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r15">15</xref></sup></p>
      <p>The interruption of vaccination in children who have post-vaccination BP is not
recommended.<sup><xref ref-type="bibr" rid="r07">7</xref></sup> In the patient
described here, vaccinations were discontinued during the period of immunosuppressive
dose of prednisolone and resumed when the dose was 0.5 mg /kg /day.</p>
      <p>Palmoplantar lesions are typical of childhood BP, especially in children under one year,
and these were the initial lesions in the case reported. The widespread involvement
predominates in infants. There were no mucosal lesions in our case, those being most
commonly found in children older than 1 year.<sup><xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r21">21</xref></sup> Such
differences in BP clinical features among infants and older children do not have defined
pathogenesis, but may be explained by differences in the expression of BP antigens
according to age.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r15">15</xref></sup> There is no difference in the prognosis or
treatment.</p>
      <p>The clinical, histopathological, DIF and IIF aspects of bullous pemphigoid can also be
observed in epidermolysis bullosa acquisita (EBA), another subepidermal bullous
disease.<sup><xref ref-type="bibr" rid="r14">14</xref></sup> To differentiate
them, we can use immunofluorescence with salt-split skin technique. In EBA and bullous
systemic lupus erythematosus, IgG deposits are only found on the dermal side of the
cleft (base of the blister), while in bullous pemphigoid deposits occur in the epidermal
side (top of the blister) or, more rarely, on both sides, since the main BP antigens are
in the upper portion of the lamina lucida.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r14">14</xref>,<xref ref-type="bibr" rid="r20">20</xref></sup></p>
      <p>In the case described here, we performed a lowcost method that determined the location
of target autoantigens. The authors used a simple staining immunohistochemistry exam for
type IV collagen in skin biopsies embedded in paraffin, allowing the differentiation of
bullous pemphigoid from other subepidermal bullous diseases. The advantage of this
method is that it is not necessary to perform new immunofluorescence reactions, with
another sets of costs and techniques.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r22">22</xref>,<xref ref-type="bibr" rid="r23">23</xref></sup> Type IV collagen is a component of the lamina densa that in bullous
pemphigoid will be detected in the base of the blister, since autoantibodies against
antigens BP180 antigen (antigen-2 PB) and BP230 antigen (antigen-1 PB) are located on
hemidesmosomes plates, above the lamina densa. EBA, characterized by autoantibodies
against type VII collagen present in the sublamina densa region, will have type IV
collagen highlighted after staining, on the top part of the blister. Therefore,
immunohistochemical staining for collagen type IV also aids in the diagnosis of
subepidermal bullous diseases.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r22">22</xref>,<xref ref-type="bibr" rid="r23">23</xref></sup></p>
      <p>BP therapy aims only to alleviate symptoms and shorten the duration of
illness.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup> Classically, the treatment of choice is performed with
systemic corticosteroids at a dose of 1 to 2 mg/kg/day of prednisone, only enough to
control the disease, and not to completely suppress the lesions.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r09">9</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r15">15</xref></sup> Oral corticosteroids are generally well
tolerated by children, and healing occurs after a few weeks or months of
treatment.<sup><xref ref-type="bibr" rid="r07">7</xref></sup> Dapsone at 100 mg
daily may be associated to systemic corticosteroids, with the aim to reduce the
corticosteroid while maintaining the sulfone as described in our case.<sup><xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r20">20</xref></sup></p>
      <p>Contrary to what is observed in adults, the prognosis of BP in children is good because
its clinical course is benign and self-limited, and lesions regress in one year or less,
with rare cases lasting two years or more.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r18">18</xref></sup> As there is a possibility of spontaneous
remission in childhood; treatment should not be aggressive or too toxic.<sup><xref ref-type="bibr" rid="r09">9</xref></sup> The occurrence of relapses is
infrequent.<sup><xref ref-type="bibr" rid="r10">10</xref></sup></p>
      <p>This disorder, although rare, should always be among the differential diagnosis of
bullous dermatoses in infants and children, especially in cases of palmar-plantar
involvement, in which the lesions are tight, wide and with an erythematous
base.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r21">21</xref></sup> The more precise knowledge of PB's pathophysiology can
incite the development of new immunomodulatory target specific treatments, with fewer
side effects than the traditional treatments.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> The clinical aspects, diagnosis, treatment and management of cases
can be challenging, so caution is advisable in theses circumstances.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r10">10</xref></sup>
This case confirmed most of the characteristics reviewed in the literature and had an
excellent response to conventional therapy, achieving remission within the usual time
frame.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Work performed at Asa Norte Regional Hospital (HRAN) - Bras&#xED;lia (DF), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial Support: None</p>
      </fn>
      <fn id="fn03" fn-type="conflict">
        <p>Conflict of Interest: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>della Torre</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Borradori</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Clinical features and practical diagnosis of bullous
pemphigoid</article-title>
          <source>Immunol Allergy Clin North Am</source>
          <year>2012</year>
          <volume>32</volume>
          <fpage>217</fpage>
          <lpage>232</lpage>
          <comment>v</comment>
          <pub-id pub-id-type="pmid">22560135</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Zenzo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Della Torre</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zambruno</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Borradori</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid: From the clinic to the bench</article-title>
          <source>Clin Dermatol</source>
          <year>2012</year>
          <volume>30</volume>
          <fpage>3</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="pmid">22137222</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oranje</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Vuzevski</surname>
              <given-names>VD</given-names>
            </name>
            <name>
              <surname>van Joost</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>ten Kate</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Naafs</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title> Bullous pemphigoid in children. Report of three cases with special
emphasis on therapy</article-title>
          <source>Int J Dermatol</source>
          <year>1991</year>
          <volume>30</volume>
          <fpage>339</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">1829723</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nemeth</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Gould</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Schachner</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Childhood bullous pemphigoid. Clinical and immunologic features,
treatment, and prognosis</article-title>
          <source>Arch Dermatol</source>
          <year>1991</year>
          <volume>127</volume>
          <fpage>378</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">1998369</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hafiji</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bhogal</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rytina</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Burrows</surname>
              <given-names>NP</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid in infancy developing after the first
vaccination</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2010</year>
          <volume>35</volume>
          <fpage>940</fpage>
          <lpage>941</lpage>
          <pub-id pub-id-type="pmid">21054491</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Barraviera</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune bullous dermatoses</article-title>
          <source>An Bras Dermatol</source>
          <year>2009</year>
          <volume>84</volume>
          <fpage>111</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">19503978</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barreau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stefan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brouard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leconte</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Morice</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Comoz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Verneuil</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Infantile bullous pemphigoid</article-title>
          <source>Ann Dermatol Venereol</source>
          <year>2012</year>
          <volume>139</volume>
          <fpage>555</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">22963966</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sousa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mota</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morgado</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dias</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid in an infant</article-title>
          <source>Acta Med Port</source>
          <year>2005</year>
          <volume>18</volume>
          <fpage>159</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">16206462</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gajic-Veljic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nikolic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Medenica</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Juvenile bullous pemphigoid: the presentation and follow-up of six
cases</article-title>
          <source>J Eur Acad Dermatol Venereol</source>
          <year>2010</year>
          <volume>24</volume>
          <fpage>69</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">19453790</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Majmudar</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Herath</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>O'Toole</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid of childhood: a rare disease with diagnostic and
management challenges</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2010</year>
          <volume>35</volume>
          <fpage>213</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="pmid">20447089</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;enz</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cirocco</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tacaronte</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Fajardo</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Calebotta</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Childhood bullous pemphigoid: a case report and 10-year follow
up</article-title>
          <source>Int J Dermatol</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>508</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="pmid">17472685</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kneisel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hertl</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune bullous skin diseases. Part 1: Clinical
manifestations</article-title>
          <source>J Dtsch Dermatol Ges</source>
          <year>2001</year>
          <volume>9</volume>
          <fpage>844</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="pmid">21955378</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lara-Corrales</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pope</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune Blistering Diseases in Children</article-title>
          <source>Semin Cutan Med Surg</source>
          <year>2010</year>
          <volume>29</volume>
          <fpage>85</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">20579597</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Balachandran</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Salt split technique: a useful tool in the diagnosis of subepidermal
bullous disorders</article-title>
          <source>Indian J Dermatol</source>
          <year>2010</year>
          <volume>55</volume>
          <fpage>334</fpage>
          <lpage>336</lpage>
          <pub-id pub-id-type="pmid">21430884</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waisbourd-Zinman</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ben-Amitai</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Feinmesser</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mimouni</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Adir-Shani</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Bullous pemphigoid in infancy: clinical and epidemiologic
characteristics</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2008</year>
          <volume>58</volume>
          <fpage>41</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">17945382</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fania</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Caldarola</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pellicano</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Feliciani</surname>
              <given-names>C</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients
and elderly individuals with pruritic dermatoses</article-title>
          <source>Clin Immunol</source>
          <year>2012</year>
          <volume>143</volume>
          <fpage>236</fpage>
          <lpage>245</lpage>
          <pub-id pub-id-type="pmid">22534318</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tampoia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Giavarina</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Di Giorgio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bizzaro</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title> Diagnostic accuracy of enzymelinked immunosorbent assays (ELISA) to
detect anti-skin autoantibodies in autoimmune blistering skin diseases: A
systematic review and meta-analysis</article-title>
          <source>Autoimmun Rev</source>
          <year>2012</year>
          <volume>12</volume>
          <fpage>121</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="pmid">22781589</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quattrino</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Silveira</surname>
              <given-names>JCGS</given-names>
            </name>
            <name>
              <surname>Kawakubo</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Xavier</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rochael</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid in childhood</article-title>
          <source>An Bras Dermatol</source>
          <year>2007</year>
          <volume>82</volume>
          <fpage>87</fpage>
          <lpage>89</lpage>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinez-De Pablo</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez-Ense&#xF1;at</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Vicente</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gilaberte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mascar&#xF3;</surname>
              <given-names>JM</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Childhood Bullous Pemphigoid: Clinical and Immunological Findings in a
Series of 4 Cases</article-title>
          <source>Arch Dermatol</source>
          <year>2007</year>
          <volume>143</volume>
          <fpage>215</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="pmid">17310001</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zanella</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Xavier</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Tebcherani</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>APG</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid in younger adults: three case
reports</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>355</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="pmid">21603823</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amos</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Flynn</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Suarez</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid in infancy: case report and literature
review</article-title>
          <source>Pediatr Dermatol</source>
          <year>1998</year>
          <volume>15</volume>
          <fpage>108</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">9572692</pub-id>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olivry</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dunston</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Usefulness of collagen IV immunostaining for diagnosis of canine
epidermolysis bullosa acquisita</article-title>
          <source>Vet Pathol</source>
          <year>2010</year>
          <volume>47</volume>
          <fpage>565</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="pmid">20375426</pub-id>
        </element-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abreu-Velez</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Collagen IV in Normal Skin and in Pathological
Processes</article-title>
          <source>N Am J Med Sci</source>
          <year>2012</year>
          <volume>4</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">22393540</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f02" orientation="portrait" position="float">
      <label>FIGURE 2</label>
      <caption>
        <p>Detail of the right thigh with annular pruriginous erythematous plaques, some topped
by blisters and tight vesicles</p>
      </caption>
      <graphic xlink:href="abd-88-06-0961-g02"/>
    </fig>
    <fig id="f03" orientation="portrait" position="float">
      <label>FIGURE 3</label>
      <caption>
        <p>Detail of the left foot with serohemorrhagic crusts</p>
      </caption>
      <graphic xlink:href="abd-88-06-0961-g03"/>
    </fig>
    <fig id="f04" orientation="portrait" position="float">
      <label>FIGURE 4</label>
      <caption>
        <p>Detail of the lower limbs with erythematous urticariform plaques topped by blister
and vesicles</p>
      </caption>
      <graphic xlink:href="abd-88-06-0961-g04"/>
    </fig>
    <fig id="f05" orientation="portrait" position="float">
      <label>FIGURE 5</label>
      <caption>
        <p>Detail of superior trunk and limbs</p>
      </caption>
      <graphic xlink:href="abd-88-06-0961-g05"/>
    </fig>
    <fig id="f08" orientation="portrait" position="float">
      <label>FIGURE 8</label>
      <caption>
        <p>HE 40x: Detail of subepidermal blister rich in neutrophils and eosinophils</p>
      </caption>
      <graphic xlink:href="abd-88-06-0961-g08"/>
    </fig>
    <fig id="f09" orientation="portrait" position="float">
      <label>FIGURE 9</label>
      <caption>
        <p>DIF: Positive reaction for IgG in subepidermal basal membrane zone</p>
      </caption>
      <graphic xlink:href="abd-88-06-0961-g09"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
